AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Shares Shorted: Short Interest Down 44.4% in October

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) saw a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 106,234 shares, a drop of 44.4% from the October 15th total of 191,030 shares. Based on an average trading volume of 225,066 shares, the short-interest ratio is currently 0.5 days.

AXIM Biotechnologies Stock Performance

OTCMKTS:AXIM opened at $0.00 on Monday. AXIM Biotechnologies has a one year low of $0.00 and a one year high of $0.03.

AXIM Biotechnologies Company Profile

(Get Free Report)

AXIM Biotechnologies, Inc. is a biotechnology company focused on developing diagnostic technologies and products. Its activities have included the research and development of rapid, point-of-care tests intended to support the detection and monitoring of medical conditions. The company has historically worked on diagnostic products related to infectious diseases, including COVID-19 testing and antibody detection. AXIM has also explored applications in oral and eye health, including diagnostic approaches designed for use with saliva and other accessible biological samples.

See Also

Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.